A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.


Updates from The Motley Fool

Latest updates on Arena Pharmaceuticals from Fool.com.  The Fool has written over 400 articles on Arena Pharmaceuticals.


Stock Performance

View Interactive ARNA Charts
Sponsored by

Key Data Points

Primary metrics and data points about Arena Pharmaceuticals.
Current Price: $24.93
Prev Close: $24.53
Open: $24.59
Bid: $24.55
Ask: $24.93
Day's Range: $24.37 - $24.94
52wk Range: $11.30 - $27.86
Volume: 278,206
Avg Vol 605,374
Market Cap: $978M
P/E (ttm): -2.84
EPS (ttm): ($8.65)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Arena Pharmaceuticals.
CAPS Rating 1 out of 5
 
758 Outperform
81 Underperform
CAPS All Stars
 
109 Outperform
21 Underperform

How do you think Arena Pharmaceuticals will perform against the market?



You pick for Arena Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Amit Munshi, CEO

100% Approve

Based on 5 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Arena Pharmaceuticals.

A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers